SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019024
Filing Date
2023-11-14
Accepted
2023-11-14 16:10:46
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20230930x10q.htm   iXBRL 10-Q 834430
2 EX-31 bpth-20230930xex31.htm EX-31 12495
3 EX-32 bpth-20230930xex32.htm EX-32 6296
  Complete submission text file 0001558370-23-019024.txt   3229001

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20230930.xsd EX-101.SCH 26500
5 EX-101.CAL bpth-20230930_cal.xml EX-101.CAL 29855
6 EX-101.DEF bpth-20230930_def.xml EX-101.DEF 93266
7 EX-101.LAB bpth-20230930_lab.xml EX-101.LAB 210803
8 EX-101.PRE bpth-20230930_pre.xml EX-101.PRE 182270
43 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20230930x10q_htm.xml XML 336283
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 231406213
SIC: 2834 Pharmaceutical Preparations